Learn more about NCI's Provocative Questions Initiative
Recent Events
Please see below for examples of our past participation.
Join SBIR at the 2010 BIO International Convention. Michael Weingarten, Director of NCI SBIR Development Center, and Greg Evans, Program Director, will each discuss new SBIR funding available for small businesses, opportunities for investors and strategic partners to collaborate with SBIR awardees, tips for applying to the SBIR program, and how to overcome commercialization challenges and enable the development of technologies to prevent, diagnose and treat cancer.
There will be two key opportunities to engage with SBIR leadership:
Panel Discussion: Novel Strategies for Surviving and Building Value in Drug Development: Bridges over the Valley of Death
Track: Finance
Session Date & Time: Tuesday, May 4, 2010, 4:00 - 5:30 p.m.
Location: McCormick Place, Chicago, IL
Room: S405A
Description:
With insights from industry and finance experts, Michael Weingarten will review the SBIR Phase II Bridge Award. The SBIR Phase II Bridge Award is a new $3M funding opportunity designed to facilitate partnerships between NCI and third-party investors (VC's, Pharmaceutical and device companies, etc.) and enable the commercialization of promising cancer therapies, imaging technologies, and diagnostics.
Also on the panel is a Bridge Awardee who will share his company's technology and explain how SBIR funding helped them attract private investors and cross the funding gap known as the "Valley of Death" that exists between the end of a Phase II award and commercialization.
This session aims to:
- Explain how emerging companies and their investors are pursuing financial strategies in capital-scarce times to get over the gap in funding colloquially called the Valley of Death.
- Provide a forum for attendees to hear real-life examples of how biotech companies obtain NCI SBIR grants and gain practical tips on how to apply.
Forum: Translational Research Forum: Translating Science, Transforming Healthcare
Track: BIO Associated Events
Session Date & Time: Monday, May 3, 2010, 8:30 a.m. - 5:30 p.m.
Room: S404A - S404BC
Location: McCormick Place Convention Center
Cost: $30 (in addition to BIO registration fee; includes a boxed lunch)
Participants are invited to the Monday TRF Reception, 4:30 - 5:30 p.m.
Description:
At 1 p.m., in the panel covering "From Invention to Patient," Greg Evans will highlight the NCI SBIR Programs (especially the Bridge grant program) and other NCI resources that can enable and assist companies in making the transition from having an invention to testing it in clinical trials. Other academic and industry thought leaders will provide real-world cases and examples of collaboration to "translate science and transform healthcare," highlighting the valuable role of the nationwide NIH Clinical and Translational Research Award (CTSA) program in this effort.
Agenda topics include:
- Public Policy Support
- From Science to Invention
- From Invention to Patient
- Case Study in Translation: Molecular Diagnostics and Biomarkers
To learn more about registration for these events at the BIO International Convention, click here.
